Option chain shows key data for 37 Cap's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for 37 Cap.

37 Cap (OTC:HHHEF) Stock, Option Chain

37 Capital Inc is a mineral exploration company principally engaged in the business of acquisition, exploration, and if warranted, the development of natural resource properties. The company's segment is the Exploration and Development of Mineral Properties. It holds interest in Extra High Property; Ontario Mineral Leases (Lithium); and Acacia Property.

37 Capital Inc

<p>Lake Street  analyst Brooks O'Neil   maintains ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) with a Buy and lowers the price target from $30 to $10.</p>


News

Price Target

Analyst Ratings

MODV

Lake Street Maintains Buy on ModivCare, Lowers Price Target to $10

<p>In the preceding three months, 14 analysts have released ratings for BKV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKV#NYSE">BKV</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">5</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $26.43, a high estimate of $33.00, and a low estimate of $23.00. Witnessing a positive shift, the current average has risen by 5.72% from the previous average price target of $25.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794859_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of BKV by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Bertrand Donnes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$30.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$33.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Bertrand Donnes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$25.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$25.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Bertrand Donnes</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Announces</td>
<td>Positive</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Buy</td>
<td>$29.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephen Richardson</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$29.00</td>
<td>-</td>
</tr>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$28.00</td>
<td>-</td>
</tr>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$23.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to BKV. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of BKV compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for BKV's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into BKV's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BKV/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on BKV analyst ratings.</strong></a></p>
<h2>Get to Know BKV Better</h2>
<p>BKV Corp is a growth-driven energy company. Its core business is to produce natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).</p>
<h3>Breaking Down BKV's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> BKV's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately <strong>-24.33%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> BKV's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>9.34%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> BKV's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>0.88%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> BKV's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.57%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> BKV's debt-to-equity ratio is below the industry average at <strong>0.12</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where BKV Stands With Analysts

<p>President Joe Biden's remaining days in office are dwindling, but one last-minute decision of his could have a major impact on the energy market that will linger long past January 20, 2025.</p>
<p>On January 6, the Biden administration banned offshore drilling in more than 625 million acres of US coastal areas, wetlands, and marine ecosystems. The drilling ban protects those areas from future oil and natural gas leases.</p>
<p><strong>Here&#8217;s how this will affect energy stocks now and in the future.</strong></p>
<p>"Using his authority under Section 12(a) of the Outer Continental Shelf Lands Act, President Biden is issuing two Presidential Memoranda to protect all U.S. Outer Continental Shelf areas off the East and West coasts, the eastern Gulf of Mexico, and additional portions of the Northern Bering Sea in Alaska from future oil and natural gas leasing," the White House said in a statement. "The withdrawals have no expiration date and prohibit all future oil and natural gas leasing in the areas withdrawn."</p>
<p>The S&amp;P Energy Index remained relatively stable the week after the drilling ban was announced, holding in the 665-to-675 range. Yet there may be limited collateral damage to select energy companies from the ban.</p>
<p>Oil and gas companies that rely on offshore drilling, particularly in restricted areas, may see reduced exploration and production opportunities, leading to potential revenue declines," said Mike Blankenship, a capital markets attorney with Winston &amp; Strawn LLP in Houston, Tex. "We will likely continue to see more drilling in the Gulf of Mexico, where regulatory hurdles might be less restrictive. The ban could also contribute to tighter domestic oil and gas supplies in the long term, potentially driving up prices if demand remains steady or increases."</p>
<p>Other energy experts say fears of a significant decline in sector share prices were overblown.</p>
<p>&#8220;President Biden's ban on oil drilling covers approximately 2.54 million square kilometers of oceanic territory, including parts of the Atlantic and Pacific coasts, sections of Alaska's northern Bering Sea, and the eastern Gulf of Mexico," said Igor Isaev, head of the analytics center at the European broker Mind Money. "To put this into perspective, the area is comparable to the size of Sudan or Algeria, which rank 10th and 11th in global landmass, while the U.S. totals 9.37 million square kilometers."</p>
<p>That said, the drilling ban doesn't affect the central and western Gulf of Mexico, which account for about 14.5% of U.S. oil production and 4% of its natural gas output, Isaev noted. "Another thing is that the newly restricted zones contain little in terms of proven reserves," he added. "While the eastern Gulf contains some forecasted but unexplored reserves, their economic viability remains questionable given the rise of onshore shale extraction."</p>
<p>Additionally, the oil and gas markets remain oversupplied through the development of existing oil and gas fields.</p>
<p>"The natural gas market has shown little reaction to the presidential elections, instead being influenced by short-term drivers like weather, storms, and LNG export demand in Europe and Asia playing a greater role," Isaev said. "We expect gas prices to rise in the near term."</p>
<p>Over the long term, the U.S. has the capacity to produce up to 14.5 million barrels of oil daily with its existing infrastructure. "Pushing production beyond this threshold would require significant investment in pipelines and drilling facilities," Isaev said. "Increased oil output would also contribute to associated gas production, and we are already seeing expansion in dedicated gas fields like Marcellus."</p>
<p>The U.S. will likely maintain stable oil and gas prices tied to the Fed's policy, global liquidity, and energy costs.</p>
<p>"The country's main goal lies in affordable, stable energy, which is why it will keep the oil prices in the range of $70–$80 per barrel, which is beneficial for the U.S., and there isn't much reason to lower prices further," Isaev noted. "While President Trump has promised to overturn the ban, history shows such actions face legal hurdles. For example, Trump's 2019 attempt to lift a similar Arctic ban was blocked, and in 2020, Trump himself extended a moratorium on offshore drilling during his presidency."</p>
<p>"Ultimately, the ban itself is unlikely to affect the oil market significantly," he added.</p>
<p>With legal hurdles in place and potential Congressional action needed, what options does the Trump administration have to overturn the drilling ban?</p>
<p>"If the ban includes elements tied to Congressional authority (e.g., restrictions codified in law), overturning it may require bipartisan approval," Blankenship said&nbsp; "This would be difficult if the political makeup of Congress is divided. The Trump administration could attempt to defund enforcement mechanisms tied to the ban, but this strategy would face its own political challenges."</p>
<p><strong>Three Energy Stocks That Should Keep Percolating</strong></p>
<p>With energy stocks experiencing no significant impact from the Biden offshore drilling ban (so far), the outperforming sector stocks should keep rolling &#8211; especially these three energy plays<strong>.</strong></p>
<p><strong>Texas Pacific Land Corp. (TPL). </strong>This energy stock is pricey at $1,293 per share, but it's been a robust performer lately. The stock is up 153.7% over the past year and the company owns 900,000 acres in the oil-rich Permian Basin.</p>
<p>The company makes big profits on oil and gas royalties and surface leases. Couple that with a debt-free balance sheet, a decent 0.49% dividend yield, and the bullish tone on oil and gas coming from the incoming Trump administration, and TPL should keep its winning streak going in 2025.</p>
<p><strong>Targa Resources (TRGP).</strong> Targa, a Houston, Tex.-based midstream natural gas and natural gas liquids services provider, is also on a roll. TRGP's stock price is up 130% over the past year. The company is in full expansion mode, building six natural gas processing centers and a new NGL export terminal, which should be up and running next year.</p>
<p>Scotiabank recently issued an "outperform" call on Targa, with a $218 price target. The stock is currently trading at $195 per share.</p>
<p><strong>Kinder Morgan (KMI). </strong>Analysts are also bullish on Houston-based Kinder Morgan, an oil and natural gas pipeline transportation services provider. KMI's share price has been up 58.5% over the past year, and it's expected to post year-over-year earnings increases when it releases earnings numbers from the last quarter of 2024. Overall, analysts expect earnings to rise by 19.9% year-to-year, and revenues are pegged to increase by 1.3% over the same period.</p>
<p><strong><a href="https://benzinga.zoom.us/webinar/register/WN_OJ2FBspHSJSSVNlW8zGapw/?utm_source=WebRD-0113&amp;el=ResearchDaily">Unlock Momentum &amp; Maximize Profits This Earnings Season</a><br /></strong>Join Ryan Faloona and Anne-Marie Baiynd on <strong>Tuesday, January 14, at 6 PM ET</strong> for an exclusive webinar. Discover strategies to master earnings season, identify momentum opportunities, and capitalize on fast-moving trends. <strong><a href="https://benzinga.zoom.us/webinar/register/WN_OJ2FBspHSJSSVNlW8zGapw/?utm_source=WebRD-0113&amp;el=ResearchDaily">Reserve your spot now!</a></strong></p>
<p>Image Via Shutterstock</p>


Opinion

Trading Ideas

3 Energy Stocks to Buy After Biden's Offshore Oil Ban

<p>In the last three months, 11 analysts have published ratings on Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $64.55, a high estimate of $73.00, and a low estimate of $52.00. Marking an increase of 0.44%, the current average surpasses the previous average price target of $64.27. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794851_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The perception of Halozyme Therapeutics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mohit Bansal</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$57.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$53.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$70.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Joseph Catanzaro</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Jason Butler</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$73.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Mitchell Kapoor</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$65.00</td>
<td>$65.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Halozyme Therapeutics. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Halozyme Therapeutics compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Halozyme Therapeutics's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Halozyme Therapeutics's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HALO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Halozyme Therapeutics analyst ratings.</strong></a></p>
<h2>Delving into Halozyme Therapeutics's Background</h2>
<p>Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.</p>
<h3>Halozyme Therapeutics's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Halozyme Therapeutics displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>34.28%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Halozyme Therapeutics's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>47.23%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Halozyme Therapeutics's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>36.92%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>6.7%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>3.32</strong>, caution is advised due to increased financial risk.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


HALO

Analyst Expectations For Halozyme Therapeutics's Future

<p>In the preceding three months, 5 analysts have released ratings for Magnolia Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $29.4, a high estimate of $34.00, and a low estimate of $24.00. This upward trend is evident, with the current average reflecting a 0.68% increase from the previous average price target of $29.20.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794842_0.png" alt="price target chart" /></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Magnolia Oil &amp; Gas. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$34.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Noah Hungness</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$24.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>William Janela</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$33.00</td>
<td>$31.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Magnolia Oil &amp; Gas. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Magnolia Oil &amp; Gas compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Magnolia Oil &amp; Gas's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Magnolia Oil &amp; Gas's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MGY/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Magnolia Oil &amp; Gas analyst ratings.</strong></a></p>
<h2>All You Need to Know About Magnolia Oil &amp; Gas</h2>
<p>Magnolia Oil &amp; Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquid (NGL) reserves. The Company's oil and natural gas properties are located in Karnes County and the Giddings area in South Texas, where the Company targets the Eagle Ford Shale and Austin Chalk formations. Its objective is to generate stock market value over the long term through consistent organic production growth, high full-cycle operating margins, and an efficient capital program with short economic paybacks. The company's operating segment is acquisition, development, exploration, and production of oil and natural gas properties located in the United States.</p>
<h3>Magnolia Oil &amp; Gas: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Magnolia Oil &amp; Gas's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>5.53%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Magnolia Oil &amp; Gas's net margin excels beyond industry benchmarks, reaching <strong>29.59%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Magnolia Oil &amp; Gas's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>5.29%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>3.49%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Magnolia Oil &amp; Gas's debt-to-equity ratio is below the industry average. With a ratio of <b>0.21</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Demystifying Magnolia Oil & Gas: Insights From 5 Analyst Reviews

<p>High-rolling investors have positioned themselves bearish on Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in LRCX often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 15 options trades for Lam Research. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 26% bullish and 73% bearish. Among all the options we identified, there was one put, amounting to $81,640, and 14 calls, totaling $1,167,460.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $50.0 to $84.0 for Lam Research over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Lam Research's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lam Research's whale activity within a strike price range from $50.0 to $84.0 in the last 30 days. </p>
<h3>Lam Research Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794833_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$13.85</td>
<td>$13.75</td>
<td>$13.75</td>
<td>$64.00</td>
<td>$345.1K</td>
<td>59</td>
<td>251</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.78</td>
<td>$1.74</td>
<td>$1.77</td>
<td>$74.00</td>
<td>$187.5K</td>
<td>2.9K</td>
<td>1.3K</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.7</td>
<td>$15.35</td>
<td>$15.7</td>
<td>$82.00</td>
<td>$81.6K</td>
<td>1.5K</td>
<td>52</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$8.95</td>
<td>$8.85</td>
<td>$8.85</td>
<td>$69.00</td>
<td>$80.5K</td>
<td>161</td>
<td>138</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$6.75</td>
<td>$6.7</td>
<td>$6.7</td>
<td>$70.00</td>
<td>$79.0K</td>
<td>1.7K</td>
<td>118</td>
</tr>
</tbody>
</table>
</p>
<h3>About Lam Research</h3>
<p>Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.</p>
<p>Having examined the options trading patterns of Lam Research, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Lam Research Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,790,682, the price of LRCX is down by -0.63%, reaching $74.18.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 16 days from now.</li>
</ul>
<h3>What The Experts Say On Lam Research</h3>
<p>Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $85.66666666666667.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Lam Research, which currently sits at a price target of $82.<br />
&#x2A; An analyst from Mizuho persists with their Outperform rating on Lam Research, maintaining a target price of $90.<br />
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on Lam Research, maintaining a target price of $85. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lam Research with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

LRCX

Market Whales and Their Recent Bets on LRCX Options

<p>6 analysts have shared their evaluations of Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $150.33, a high estimate of $166.00, and a low estimate of $125.00. This current average has decreased by 3.12% from the previous average price target of $155.17. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794834_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Xylem. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$147.00</td>
<td>$148.00</td>
</tr>
<tr>
<td>Nathan Jones</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$166.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Andrew Kaplowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$148.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Joseph Giordano</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$125.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$162.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Michael Halloran</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$154.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Xylem. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Xylem compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Xylem's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Xylem's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/XYL/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Xylem analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Xylem</h2>
<p>Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $7.4 billion in revenue in 2023.</p>
<h3>Financial Milestones: Xylem's Journey</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> Xylem displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>1.35%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>10.31%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Xylem's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>2.07%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Xylem's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>1.36%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Xylem's debt-to-equity ratio is below the industry average at <strong>0.2</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Deep Dive Into Xylem Stock: Analyst Perspectives (6 Ratings)

<p>Deep-pocketed investors have adopted a bullish approach towards Suncor Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SU#NYSE">SU</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SU usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Suncor Energy. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 75% leaning bullish and 12% bearish. Among these notable options, 4 are puts, totaling $176,950, and 4 are calls, amounting to $308,856.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $44.0 for Suncor Energy over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Suncor Energy options trades today is 806.71 with a total volume of 3,243.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Suncor Energy's big money trades within a strike price range of $15.0 to $44.0 over the last 30 days.</p>
<h3>Suncor Energy Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794827_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$10.75</td>
<td>$10.65</td>
<td>$10.65</td>
<td>$30.00</td>
<td>$165.1K</td>
<td>288</td>
<td>175</td>
</tr>
<tr>
<td>SU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$24.95</td>
<td>$24.25</td>
<td>$24.95</td>
<td>$15.00</td>
<td>$74.8K</td>
<td>138</td>
<td>30</td>
</tr>
<tr>
<td>SU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.65</td>
<td>$3.55</td>
<td>$3.55</td>
<td>$43.00</td>
<td>$56.8K</td>
<td>87</td>
<td>191</td>
</tr>
<tr>
<td>SU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.81</td>
<td>$0.77</td>
<td>$0.78</td>
<td>$39.00</td>
<td>$46.8K</td>
<td>1.6K</td>
<td>1.2K</td>
</tr>
<tr>
<td>SU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.79</td>
<td>$0.75</td>
<td>$0.75</td>
<td>$39.00</td>
<td>$45.0K</td>
<td>1.6K</td>
<td>605</td>
</tr>
</tbody>
</table>
</p>
<h3>About Suncor Energy</h3>
<p>Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil production, petroleum refining in Canada and the U.S., and the company's Petro-Canada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, and renewable fuels. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power. The company's operating segments include Oil Sands, Exploration and Production, and Refining and Marketing. Geographically, the company generates a majority of its revenue from Canada.</p>
<p>Having examined the options trading patterns of Suncor Energy, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Suncor Energy</h3>
<ul>
<li>With a volume of 3,916,881, the price of SU is up 1.74% at $40.06. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 37 days.</li>
</ul>
<h3>Professional Analyst Ratings for Suncor Energy</h3>
<p>A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $66.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $66.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $66. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Suncor Energy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Suncor Energy's Options Frenzy: What You Need to Know

<p>Ratings for ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $151.5, a high estimate of $180.00, and a low estimate of $100.00. This current average reflects an increase of 12.01% from the previous average price target of $135.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794826_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>A clear picture of ARM Holdings's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$162.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Timothy Arcuri</td>
<td>UBS</td>
<td>Announces</td>
<td>Buy</td>
<td>$160.00</td>
<td>-</td>
</tr>
<tr>
<td>Joe Quatrochi</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$155.00</td>
<td>-</td>
</tr>
<tr>
<td>Ananda Baruah</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Harlan Sur</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$160.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Toshiya Hari</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$159.00</td>
<td>$144.00</td>
</tr>
<tr>
<td>Chris Rolland</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$118.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Blayne Curtis</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$145.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Mark Lipacis</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$176.00</td>
<td>$173.00</td>
</tr>
<tr>
<td>Sara Russo</td>
<td>Bernstein</td>
<td>Maintains</td>
<td>Underperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to ARM Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ARM Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for ARM Holdings's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of ARM Holdings's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ARM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on ARM Holdings analyst ratings.</strong></a></p>
<h2>Delving into ARM Holdings's Background</h2>
<p>Arm Holdings is the IP owner and developer of the ARM architecture (ARM stands for Acorn RISC Machine), which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allows them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Off-the-shelf and architectural customers pay a royalty fee per chip shipped.</p>
<h3>Understanding the Numbers: ARM Holdings's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> ARM Holdings's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>4.71%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> ARM Holdings's net margin excels beyond industry benchmarks, reaching <strong>12.68%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> ARM Holdings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>1.83%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>1.34%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.04</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Demystifying ARM Holdings: Insights From 10 Analyst Reviews

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Pure Storage</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with PSTG, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 9 options trades for <strong>Pure Storage</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 33% bullish and 44%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $54,045, and 8, calls, for a total amount of $386,059.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $75.0 for Pure Storage over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Pure Storage options trades today is 697.33 with a total volume of 982.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Pure Storage's big money trades within a strike price range of $15.0 to $75.0 over the last 30 days.</p>
<h3>Pure Storage Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794821_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PSTG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$6.4</td>
<td>$6.0</td>
<td>$6.19</td>
<td>$75.00</td>
<td>$84.1K</td>
<td>203</td>
<td align="right">136</td>
</tr>
<tr>
<td>PSTG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$47.9</td>
<td>$47.6</td>
<td>$47.8</td>
<td>$15.00</td>
<td>$57.3K</td>
<td>66</td>
<td align="right">12</td>
</tr>
<tr>
<td>PSTG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.35</td>
<td>$1.2</td>
<td>$1.2</td>
<td>$55.00</td>
<td>$54.0K</td>
<td>809</td>
<td align="right">450</td>
</tr>
<tr>
<td>PSTG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.5</td>
<td>$17.3</td>
<td>$17.3</td>
<td>$45.00</td>
<td>$51.9K</td>
<td>2.1K</td>
<td align="right">130</td>
</tr>
<tr>
<td>PSTG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.1</td>
<td>$16.9</td>
<td>$16.9</td>
<td>$45.00</td>
<td>$50.6K</td>
<td>2.1K</td>
<td align="right">90</td>
</tr>
</tbody>
</table>
</p>
<h3>About Pure Storage</h3>
<p>Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue which includes the sale of integrated storage hardware and embedded operating system software and; subscription services revenue which includes Evergreen Storage subscriptions, a unified subscription which includes Pure as-a-Service, and Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.</p>
<h3>Pure Storage's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,493,476, the price of PSTG is down by -2.9%, reaching $62.85.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 44 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Pure Storage</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $72.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Pure Storage with a target price of $72. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pure Storage with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


PSTG

Pure Storage's Options: A Look at What the Big Money is Thinking

<p>Analysts' ratings for Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) over the last quarter vary from bullish to bearish, as provided by 19 analysts.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">14</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Blackstone, presenting an average target of $175.11, a high estimate of $230.00, and a low estimate of $134.00. This current average reflects an increase of 11.65% from the previous average price target of $156.84. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736794812_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The perception of Blackstone by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Brown</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$174.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$192.00</td>
<td>$199.00</td>
</tr>
<tr>
<td>Crispin Love</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$179.00</td>
<td>$168.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$175.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Etienne Ricard</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$157.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$195.00</td>
<td>$188.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$199.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$230.00</td>
<td>$149.00</td>
</tr>
<tr>
<td>Brian Brungardt</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$182.00</td>
<td>$172.00</td>
</tr>
<tr>
<td>Chris Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Glenn Schorr</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$181.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$192.00</td>
<td>$171.00</td>
</tr>
<tr>
<td>Bill Katz</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$149.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$146.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Alexander Blostein</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$174.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Etienne Ricard</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$134.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$188.00</td>
<td>$169.00</td>
</tr>
<tr>
<td>Brennan Hawken</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$140.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Blackstone. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Blackstone compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Blackstone's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Blackstone analyst ratings.</strong></a></p>
<h2>All You Need to Know About Blackstone</h2>
<p>Blackstone is the world's largest alternative-asset manager with $1.108 trillion in total asset under management, including $820.5 billion in fee-earning assets under management, at the end of September 2024. The company has four core business segments: private equity (25% of fee-earning AUM and 30% of base management fees), real estate (35% and 39%), credit and insurance (31% and 24%), and multi-asset investing (9% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).</p>
<h3>Breaking Down Blackstone's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Blackstone's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>35.15%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Blackstone's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>27.05%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Blackstone's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>11.28%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Blackstone's ROA excels beyond industry benchmarks, reaching <strong>1.88%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Blackstone's debt-to-equity ratio surpasses industry norms, standing at <strong>1.7</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


The Analyst Verdict: Blackstone In The Eyes Of 19 Experts

<p><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) faces several key macroeconomic data releases this week, causing heightened volatility <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42946401/bitcoin-down-8-in-a-week-what-does-technical-analysis-say">in the markets</a>.</p>
<p><strong>What Happened: </strong>The Kobeissi Letter pointed to a packed key economic events week which includes the December Producer Price Inflation on Tuesday, Consumer Price Inflation on Wednesday, Retail Sales on Thursday and the Philadelphia Fed Manufacturing Index on Thursday.</p>
<p>Additionally, seven Fed speakers are <a href="https://x.com/KobeissiLetter/status/1878435161932443921">scheduled</a>, making it a critical week for inflation data and Federal Reserve insights.</p>
<p>Crypto trader Michael van de Poppe speculated about the possibility of a classic &#8220;Sell the Rumor, Buy the News&#8221; event and questioned whether the catalyst could be PPI, CPI or even the President&#8217;s inauguration on Jan. 20.</p>
<p>He <a href="https://x.com/CryptoMichNL/status/1878847979672502425">noted</a> a significant selloff across altcoins to start the year.</p>
<p>Prominent analyst Alex Krüger <a href="https://x.com/krugermacro/status/1878860525305790670">observed</a> that that equities often crash overnight into Monday, hitting local bottoms by the U.S. cash open, particularly after a weak prior week. </p>
<p>With CPI data and Trump's inauguration adding uncertainty, he expects heightened volatility.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42908193/exclusive-answering-key-questions-about-bitcoins-future-before-inauguration">EXCLUSIVE: Answering Key Questions About Bitcoin&#8217;s Future 10 Days Before The Inauguration</a></strong></p>
<p><strong>What's Next:</strong> Kevin, a prominent crypto analyst, highlighted that the macro environment, characterized by rising DXY and 10-year Treasury yields, supports Bitcoin dominance as investors seek perceived lower-risk assets. </p>
<p>This dynamic could continue to hinder altcoins, delaying any hope for an altseason.</p>
<p>From a technical <a href="https://x.com/Kev_Capital_TA/status/1878669080913432696">perspective</a>, Bitcoin dominance is forming an inverse head-and-shoulders pattern on the 4-hour chart, targeting 59.5% dominance.</p>
<p>The altcoin cycle faces significant risks due to a lack of major monetary policy changes, further deviating from historical patterns.</p>
<p>Chart analyst Ali Martinez pointed out a steep decline in crypto market capital inflows—down 56.7% over the past month, from $134 billion to $58 billion. </p>
<p>This sharp decline in investment activity could serve as a warning to traders.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Capital inflows into the cryptocurrency market have declined by 56.70% over the past month, dropping from $134 billion to $58 billion. This points to a significant reduction in investment activity. <a href="https://t.co/B0MmGs3t96">pic.twitter.com/B0MmGs3t96</a></p>
<p>&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1878646904994562062?ref_src=twsrc%5Etfw">January 13, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42919731/bitcoin-to-bounce-back-in-q1-but-beware-20-corrections-analysts-warn">Bitcoin To Bounce Back In Q1 But Beware 20% Corrections, Analysts Warn</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin's Big Macro Data Week: Here's What To Watch

<p>JP Morgan  analyst Tami Zakaria   maintains PACCAR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) with a Overweight and raises the price target from $122 to $125.</p>


PCAR

JP Morgan Maintains Overweight on PACCAR, Raises Price Target to $125

<p><strong>Telsey Advisory Group </strong>analyst Dana Telsey maintained a Market Perform rating on <strong>Nordstrom In</strong>c (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) <a target="_blank" href="https://www.benzinga.com/quote/JWN/analyst-ratings" rel="noreferrer noopener">with a price target of $24.00.</a></p>
<p>For the nine-week period ending January 4, 2025, the company reported a 4.9% year-over-year increase in total net sales, outperforming the previous consensus estimate of a 4.7% <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42927723/nordstrom-reports-holiday-sales-updates-outlook" rel="noreferrer noopener">decline for the fourth quarter, per the analyst</a>.</p>
<p>Same-store sales at the group level rose by 5.8% year-over-year, surpassing the consensus estimate of a 3.5% decline for the quarter.</p>
<p>Following stronger-than-anticipated holiday results, the company revised its revenue guidance higher, but maintained its profitability projections for the year.</p>
<p>The analyst says that Nordstrom reported stronger-than-expected holiday sales, with positive performance at both the Nordstrom and Rack banners, driven by effective promotional strategies and a compelling product selection.</p>
<p>The company raised its fiscal 2024 revenue guidance, showcasing its resilience in a highly competitive retail landscape, asserted the analyst.</p>
<p>However, the analyst added that the company reiterated its full-year EPS forecast, slightly lower than the previous year, reflecting potential gross margin pressure due to efforts to remain competitive.</p>
<p>With earnings exceeding expectations in the second and third quarters, the company demonstrated improved momentum, said the analyst.</p>
<p>According to the analyst, the Nordstrom Rack division also presents growth potential, benefiting from a stronger off-price market that sets it apart from other department store chains.</p>
<p><strong>Goldman Sachs</strong> analyst Brooke Roach is optimistic about Nordstrom&#8217;s sequential strength during the holiday period, as both banners showed improved comparable sales trends.</p>
<p>However, the analyst expects investors to pay close attention to management&#8217;s comments about their strategies to stay competitive in the promotional environment.</p>
<p>The analyst notes the anticipated January revenue slowdown in JWN&#8217;s guidance is likely a conservative estimate. Still, factors such as winter weather, wildfires in California, and other variables could contribute to the expected slower growth as the quarter ends, per the analyst.</p>
<p>The company is slated to release its fourth-quarter financial results on March 4, 2025.</p>
<p><strong>Price Action</strong>: JWN shares are trading higher by 0.55% at $24.14 at the last check Monday.</p>
<p><em>Photo via Shutterstock.</em></p>


Analyst Color

Equities

Reiteration

General

Nordstrom Balances Strong Holiday Sales And Competition, Analysts Highlight Margin Pressure

<p>In what could be a landmark ruling, a Florida appeals court has determined that a drug-sniffing dog&#8217;s alert alone does not justify a police search of a vehicle, particularly in the era of legalized medical marijuana.</p>
<p><strong>Why? </strong>The court ruled that since a dog cannot distinguish between medical and illegal marijuana, its alert does not provide sufficient probable cause. </p>
<p><strong>What Happened</strong>: The case stemmed from a 2020 traffic stop where a police officer called for a drug-sniffing dog after stopping a Lyft car for speeding and faulty lights, <a href="https://www.news4jax.com/news/local/2025/01/08/florida-judge-rules-police-dogs-trained-to-alert-on-cannabis-cant-be-the-only-reason-used-to-justify-a-vehicle-search/">reported</a> News4Jax. Upon arrival, the dog alerted authorities to the presence of drugs, leading to a search that uncovered marijuana, crack cocaine, ecstasy and methamphetamine, leading to the arrest of the passenger, <strong>Stephon Ford</strong>.</p>
<p>A circuit judge refused to suppress the evidence, noted the outlet, but the appeals court sided with Ford who argued that the dog could not differentiate between medical marijuana and illegal substances. The court stated that without knowing whether the dog detected illegal drugs or legally possessed medical marijuana, the alert could not provide the necessary probable cause for a warrantless search. The cannabis found, by the way, was not <a href="https://www.benzinga.com/topic/medical-cannabis">medical marijuana</a>. </p>
<p>In a concurring opinion, Judge <strong>Jordan Pratt</strong> noted that this ruling, along with a previous decision regarding the odor of marijuana, reflects the &#8220;collateral consequences&#8221; of cannabis legalization. While medical marijuana is legal in Florida, it remains illegal under federal law.  </p>
<h1 class="wp-block-heading"><strong>Limitations On Canine Searches</strong></h1>
<p>Judge Pratt clarified that the ruling does not entirely eliminate the use of drug-sniffing dogs in vehicle searches. Dogs trained to specifically alert to illegal substances can still provide probable cause for a search.</p>
<p>"An alert by a dog trained not to alert to cannabis — or to alert to cannabis differently than it alerts to other drugs — can still on its own supply probable cause," Pratt wrote. "And for another thing, even without such canine training, an undifferentiated alert can supply probable cause when combined with an officer's questions ruling out the presence of lawful cannabis. Officers easily can be trained to ask such questions in conjunction with a dog's undifferentiated alert."</p>
<p><strong>Now Read:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/01/42935445/high-times-magazine-executive-pleads-guilty-in-securities-fraud-scheme-20-million-from-investor-victims"><strong>High Times Magazine Executive Pleads Guilty In Securities Fraud Scheme &#8211; $20 Million From &#8216;Investor-Victims&#8217;</strong></a></li>
</ul>
<p><em>Photo:  Yakobchuk Viacheslav via Shutterstock</em></p>


Cannabis

Government

Legal

Can A K-9 Drug Sniffer Land You In Jail For Cannabis? Florida Court Sets New Limits

<p>JP Morgan  analyst Kian Abouhossein   maintains Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) with a Neutral and raises the price target from $104 to $108.</p>


JP Morgan Maintains Neutral on Morgan Stanley, Raises Price Target to $108

<p>Shares of<strong> Mondelez International, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>) are trading flat Monday. But the stock has been in a steep decline.</p>
<p>There is a good chance the selloff is almost over. There is also a good chance that the stock reverses and moves higher. This is why it is our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.</p>
<p>Mondelez is very oversold.</p>
<p>Most of the time a stock stays within what would be its typical or usual trading range. Once aggressive sellers push the price below this range, traders say it is oversold.</p>
<p>This could draw buyers into the market. They will be anticipating a reversion to the mean, or a move higher. Their buying could push the price up.</p>
<p>Mondelez also recently had a day where a huge amount of volume traded. This could signal a capitulation and could also be a bullish dynamic.</p>
<p><strong>Read Also:</strong> <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42944934/wall-street-slashes-interest-rate-cut-bets-after-jobs-data-are-hikes-back-on-the-table"><strong>Wall Street Slashes Interest Rate Cut Bets After Jobs Data: Are Hikes Back On The Table?</strong></a></p>
<p>Capitulations occur when traders and investors ‘throw in the towel.' They get sick of watching the stock head lower. They wait for a reversal so they can sell their shares at higher prices but the reversal never comes.</p>
<p>As a result, they decide to sell all of their shares regardless of the price. This causes a large amount of volume to trade.</p>
<p>After this, if buyers enter the market, they will have a difficult time finding someone to buy shares from. They may be forced to bid premiums to draw the attention of sellers and this could force the stock into an uptrend.</p>
<p>As you can see on the chart below, Mondelez is also getting close to a price level that has been support in the past. In the market, there tends to be support at levels that were previously support because of ‘seller's remorse'.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="550" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13134421/18-1024x550.png" alt="" class="wp-image-731118" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13134421/18-1024x550.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13134421/18-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13134421/18-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/13134421/18.png 1516w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>There are people who sold at the support who regretted doing so when the price rallied soon after. Many traders decided to buy their shares back, assuming they could buy shares for the same price they were sold at.</p>
<p>So, if the stock eventually returns to the selling price, they will place buy orders. If there are enough of these orders, it will create support at the level that had been support before.</p>
<p>This combination of being oversold, close to support, and having a potential capitulation means there is a good chance the selloff in <a href="https://www.benzinga.com/quote/MDLZ">Mondelez</a> soon ends. There is also a chance the stock will reverse and head higher.</p>
<p><strong>Read Next:</strong> </p>
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/01/42953761/santa-ana-winds-return-as-la-wildfire-damage-estimates-rise-to-at-least-250-billion-fire-officials-investigate-downed-power-lines"><strong>Santa Ana Winds Return As LA Wildfire Damage Estimates Rise To At Least $250 Billion, Fire Officials Investigate Downed Power Lines</strong></a></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Technicals

MDLZ

Stock Of The Day: Will Mondelez Rally? There's A Chance The Selloff Will End

<p>JP Morgan  analyst Eric Joseph   upgrades IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) from Underweight to Neutral.</p>


Upgrades

IGMS

JP Morgan Upgrades IGM Biosciences to Neutral

<p>Compass Point  analyst Casey Alexander   maintains Saratoga Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAR#NYSE">SAR</a>) with a Buy and lowers the price target from $26.25 to $25.25.</p>


Compass Point Maintains Buy on Saratoga Investment, Lowers Price Target to $25.25

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Booking Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with BKNG, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 52 uncommon options trades for Booking Holdings.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 40% bullish and 30%, bearish.</p>
<p>Out of all of the special options we uncovered, 22 are puts, for a total amount of $2,366,480, and 30 are calls, for a total amount of $2,064,351.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $3100.0 to $6600.0 for Booking Holdings over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Booking Holdings's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Booking Holdings's significant trades, within a strike price range of $3100.0 to $6600.0, over the past month.</p>
<h3>Booking Holdings Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1736793933_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$156.6</td>
<td>$131.6</td>
<td>$133.0</td>
<td>$3100.00</td>
<td>$665.0K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$353.1</td>
<td>$333.2</td>
<td>$338.0</td>
<td>$4800.00</td>
<td>$405.6K</td>
<td align="right">27</td>
<td align="right">12</td>
</tr>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$622.8</td>
<td>$597.8</td>
<td>$600.0</td>
<td>$5000.00</td>
<td>$300.0K</td>
<td align="right">55</td>
<td align="right">1</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$204.7</td>
<td>$191.5</td>
<td>$196.06</td>
<td>$5200.00</td>
<td>$235.2K</td>
<td align="right">51</td>
<td align="right">12</td>
</tr>
<tr>
<td>BKNG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$198.0</td>
<td>$189.8</td>
<td>$189.8</td>
<td>$4350.00</td>
<td>$208.7K</td>
<td align="right">23</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Booking Holdings</h3>
<p>Booking is the world's largest online travel agency by sales, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates several branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.</p>
<p>Having examined the options trading patterns of Booking Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Booking Holdings</h3>
<ul>
<li>Trading volume stands at 100,917, with BKNG's price up by 0.33%, positioned at $4755.0.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 38 days.</li>
</ul>
<h3>What Analysts Are Saying About Booking Holdings</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $5624.4.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JMP Securities has decided to maintain their Market Outperform rating on Booking Holdings, which currently sits at a price target of $6100.<br />
&#x2A; An analyst from Mizuho persists with their Outperform rating on Booking Holdings, maintaining a target price of $6000.<br />
&#x2A; An analyst from Morgan Stanley persists with their Equal-Weight rating on Booking Holdings, maintaining a target price of $5000.<br />
&#x2A; An analyst from B of A Securities has decided to maintain their Neutral rating on Booking Holdings, which currently sits at a price target of $5522.<br />
&#x2A; Maintaining their stance, an analyst from Wedbush continues to hold a Outperform rating for Booking Holdings, targeting a price of $5500. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Booking Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Comments

37 Cap

37 Cap (HHHEF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga